|
Mean age (years) (SD)
|
39 (8.7)
|
|
Sex
| |
|
Male, n (%)
|
30 (63.8)*
|
|
HIV infection & Antiretroviral treatment
| |
|
Median nadir CD4 count (cells/μL) (IQR)
|
153 (85–247)
|
|
Median CD4 count at the time of evaluation (cells/μL) (IQR)
|
264 (158–361)
|
|
HIV viral load undetectable (<20 copies/μL) at the time of evaluation, n (%)
|
34 (72.3)
|
|
Median duration of antiretroviral treatment (months) (IQR)
|
17.5 (4–32.5)
|
|
Tuberculosis and anti-TB treatment
| |
|
Multidrug-resistant TB (MDR-TB), n (%)
|
44 (93.6)
|
|
Extensively and extremely drug-resistant TB (XDR & XXDR-TB), n (%)
|
3 (6.4)
|
|
Extra-pulmonary TB
|
14 (29.8)
|
|
Median duration of anti-TB treatment (months) (IQR)
|
13 (4–21)
|
